Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Powderly

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
Annals of Internal Medicine|May 19, 2020
COVID-19 and Outpatient Parenteral Antimicrobial Therapy: The Need to Protect Vulnerable Medicare BeneficiariesYasir Hamad, Karen E Joynt Maddox, William G Powderly
Annals of Internal Medicine|January 18, 2021
COVID-19 and Outpatient Parenteral Antimicrobial TherapyYasir Hamad, Karen E Joynt-Maddox, William G Powderly
AIDS (London, England)|August 17, 2005
Antiretroviral resistance among HIV-positive pregnant women who have antiretroviral experience from previous pregnancyEdgar T Overton, Somnuek Sungkanuparph, Diana Nurutdinova, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2016
Impact of Infectious Diseases Consultation on Mortality of Cryptococcal infection in Patients without HIVAndrej Spec, Margaret A Olsen, Krunal Raval, et al.
AIDS Research and Human Retroviruses|October 9, 2010
HIV type 1 alters mesenchymal stem cell differentiation potential and cell phenotype ex vivoEoin J Cotter, Nicholas Chew, William G Powderly, et al.
Open Forum Infectious Diseases|February 17, 2018
Creation and Assessment of a Clinical Predictive Calculator and Mortality Associated With <i>Candida krusei</i> Bloodstream InfectionsRyan Kronen, Kevin Hsueh, Charlotte Lin, et al.
Open Forum Infectious Diseases|December 6, 2018
EQUAL <i>Cryptococcus</i> Score 2018: A <i>E</i>uropean Confederation of Medical Mycology Score Derived From Current Guidelines to Measure <i>QUAL</i>ity of Clinical Cryptococcosis ManagementAndrej Spec, Carlos Mejia-Chew, William G Powderly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
Comparative Epidemiology and Outcomes of Human Immunodeficiency virus (HIV), Non-HIV Non-transplant, and Solid Organ Transplant Associated Cryptococcosis: A Population-Based StudyIge A George, Andrej Spec, William G Powderly, et al.
Mycoses|October 16, 2020
Treatment and mortality outcomes in patients with other extrapulmonary cryptococcal disease compared with central nervous system diseaseCarlos Mejia-Chew, Abby Sung, Lindsey Larson, et al.
Antiviral Research|January 24, 2007
HIV1 protease inhibitors selectively induce inflammatory chemokine expression in primary human osteoblastsAndrea P Malizia, Mihai H Vioreanu, Peter P Doran, et al.
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Annals of Internal Medicine|May 19, 2020
COVID-19 and Outpatient Parenteral Antimicrobial Therapy: The Need to Protect Vulnerable Medicare BeneficiariesYasir Hamad, Karen E Joynt Maddox, William G Powderly
Annals of Internal Medicine|January 18, 2021
COVID-19 and Outpatient Parenteral Antimicrobial TherapyYasir Hamad, Karen E Joynt-Maddox, William G Powderly
AIDS (London, England)|August 17, 2005
Antiretroviral resistance among HIV-positive pregnant women who have antiretroviral experience from previous pregnancyEdgar T Overton, Somnuek Sungkanuparph, Diana Nurutdinova, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2016
Impact of Infectious Diseases Consultation on Mortality of Cryptococcal infection in Patients without HIVAndrej Spec, Margaret A Olsen, Krunal Raval, et al.
AIDS Research and Human Retroviruses|October 9, 2010
HIV type 1 alters mesenchymal stem cell differentiation potential and cell phenotype ex vivoEoin J Cotter, Nicholas Chew, William G Powderly, et al.
Open Forum Infectious Diseases|February 17, 2018
Creation and Assessment of a Clinical Predictive Calculator and Mortality Associated With <i>Candida krusei</i> Bloodstream InfectionsRyan Kronen, Kevin Hsueh, Charlotte Lin, et al.
Open Forum Infectious Diseases|December 6, 2018
EQUAL <i>Cryptococcus</i> Score 2018: A <i>E</i>uropean Confederation of Medical Mycology Score Derived From Current Guidelines to Measure <i>QUAL</i>ity of Clinical Cryptococcosis ManagementAndrej Spec, Carlos Mejia-Chew, William G Powderly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
Comparative Epidemiology and Outcomes of Human Immunodeficiency virus (HIV), Non-HIV Non-transplant, and Solid Organ Transplant Associated Cryptococcosis: A Population-Based StudyIge A George, Andrej Spec, William G Powderly, et al.
Mycoses|October 16, 2020
Treatment and mortality outcomes in patients with other extrapulmonary cryptococcal disease compared with central nervous system diseaseCarlos Mejia-Chew, Abby Sung, Lindsey Larson, et al.
Antiviral Research|January 24, 2007
HIV1 protease inhibitors selectively induce inflammatory chemokine expression in primary human osteoblastsAndrea P Malizia, Mihai H Vioreanu, Peter P Doran, et al.
Pageof 15